Home / Pharmaceutical company intelligence
Himont Pharmaceuticals (Pvt.) Ltd. site mark
Pharmaceutical company intelligence

Himont Pharmaceuticals products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Lahore · Pakistan

Pakistan pharmaceutical and herbal healthcare company with prescription, herbal, dermatology and consumer-health product lines.

Himont Pharmaceuticals products in Pakistan

Himont Pharmaceuticals (Pvt.) Ltd has 70 medicine presentations registered in Pakistan under 33 brands, covering 30 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and Hematology & thrombosis. Its brands with the most registered strengths and packs are Clotles SS (Enoxaparin), Novosef (Ceftriaxone), Himet (Metformin) and Akafin (Ibuprofen). 70 products have an official DRAP price on MedInfoBase. See all 33 brands A to Z

Database-driven profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public source rechecked
Latest regulatory-source observation13 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date27 Jul 2026Newest effective date among published current price records
Corporate profile evidence3 sourcesCorporate source details checked 15 Oct 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public source rechecked
Company type
Private pharmaceutical manufacturer
Phone
042-35813828
Corporate source details checked
15 Oct 2026
Corporate profile completeness
75%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000231 Himont Pharmaceuticals (Pvt) Ltd. · Punjab
Basic Manufacture 000621 Himont Pharmaceuticals (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000231 70 linked products · source seen 13 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Exact site not yet sourced

No exact premises location is published without a defensible source.

Open in Google Maps ↗ The Google Maps search link uses the company name and available city/country context; it is not presented as a verified premises pin.
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx72public portfolio records represented
REG67unique registrations represented
IDX3indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER40registry-verified exact registrations
PKR70current validated price records
G30generic molecules in indexed catalogue
DF6dosage-form groups
TA8therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage97%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage99%
priced packs safely normalized per unit
Comparable-market coverage91%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixHimont Pharmaceuticals (Pvt.) Ltd.Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/himont-pharmaceuticals-pvt-ltdGenerated 13 Nov 2026Anti-infectives32 · 46%Cardiovascular10 · 14%Hematology & thrombosis10 · 14%Endocrine & metabolic10 · 14%Pain & musculoskeletal3 · 4%CNS & mental health2 · 3%Gastrointestinal & hepatology2 · 3%Other therapeutic areas1 · 1%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioHimont Pharmaceuticals (Pvt.) Ltd.Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/himont-pharmaceuticals-pvt-ltdGenerated 13 Nov 202670presentationsTablet34 · 49%Injection21 · 30%Capsule7 · 10%Suspension5 · 7%Pessary2 · 3%Granules1 · 1%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionHimont Pharmaceuticals (Pvt.) Ltd.Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/himont-pharmaceuticals-pvt-ltdGenerated 13 Nov 202664comparable productsBelow peer median16 · 25%Near peer median6 · 9%Above peer median42 · 66%Company median price position+17.3%Lowest-price equivalents3Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsHimont Pharmaceuticals (Pvt.) Ltd.Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/himont-pharmaceuticals-pvt-ltdGenerated 13 Nov 2026Nabiqasim Industries (Pvt) Ltd.,24 shared80% overlapMediate Pharmaceutical Pvt Ltd22 shared73% overlapBosch Pharmaceuticals (Pvt) Ltd.21 shared70% overlapMacter International Limited20 shared67% overlapZafa Pharmaceutical Laboratories (P…20 shared67% overlapBio-Labs(Pvt) Ltd20 shared67% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Tablet34 products
Injection21 products
Capsule7 products
Suspension5 products
Pessary2 products
Granules1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Himont Pharmaceuticals (Pvt.) Ltd. is priced against the market

64 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers65Distinct registrations among indexed, published, presentation-validated products only
Verified price observations70
Products with a verified price70
Products with multiple price observations0
Source records with multiple versions69
Latest portfolio source check22 Sep 2026
Latest effective price date27 Jul 2026
Latest source observation13 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

67 unique registration(s) · 3 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Atrocard Atorvastatin 10 mg Tablet 10's 031844 PKR 447.51 PKR 44.75/tablet 🔒 Pharma Pro
Atrocard Atorvastatin 20 mg Tablet 10's 031845 PKR 764.36 PKR 76.44/tablet 🔒 Pharma Pro
Atrocard Atorvastatin 40 mg Tablet 10's 031846 PKR 1,042.30 PKR 104.23/tablet 🔒 Pharma Pro
A to Z

All 33 Himont Pharmaceuticals brands in Pakistan

  • Akafin Ibuprofen · 100 mg/5 mL suspension, 200 mg tablet, 400 mg tablet
  • Atrocard Atorvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
  • Azomont Azithromycin · 250 mg capsule, 500 mg tablet
  • C-Mox Fort Dry Susp Amoxicillin + clavulanic acid · 250 mg + 62.5 mg / 5 mL suspension
  • Cardil Enalapril · 10 mg tablet, 5 mg tablet
  • Cardiosil Amlodipine · 5 mg tablet
  • Clamont Granules Clarithromycin · 125 mg granules
  • Clamont Tabs Clarithromycin · 250 mg tablet, 500 mg tablet
  • Clotles SS Enoxaparin · 20 mg injection, 40 mg injection, 60 mg injection
  • Clotles Tabs Clopidogrel · 75 mg tablet
  • Diocid Gliclazide · 30 mg tablet, 60 mg tablet, 80 mg tablet
  • Eglocard Simvastatin · 10 mg tablet, 20 mg tablet
  • Hiject Cefuroxime · 1.5 g injection, 250 mg injection, 750 mg injection
  • Himet Metformin · 1 g tablet, 500 mg tablet, 850 mg tablet
  • Himovir Tenofovir disoproxil · 300 mg tablet
  • Hipram Tabs Citalopram · 20 mg tablet
  • Hipres Tabs Escitalopram · 20 mg tablet
  • Hixamic Tranexamic acid · 500 mg/5 mL injection
  • Hizolid Tabs Linezolid · 600 mg tablet
  • Imazole Clotrimazole · 100 mg pessary, 500 mg pessary
  • Klofix Omeprazole · 10 mg capsule, 20 mg capsule
  • Locgin Tabs Moxifloxacin · 400 mg tablet
  • Novosef Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
  • Orcid Ciprofloxacin · 250 mg tablet, 500 mg tablet
  • Sedinor Loratadine · 10 mg tablet
  • Sefoban Cefotaxime · 0.25 g injection, 0.5 g injection, 1.0 g injection
  • THININ Heparin sodium · 5000 IU/mL injection
  • Tysen Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 400 mg capsule
  • Xesafin Dry Susp Cephalexin · 250 mg/5 mL suspension
  • Xesafin Susp Cephalexin · 125 mg/5 mL suspension
  • Xesfain Cephalexin · 250 mg capsule, 500 mg capsule
  • Zeljin Empagliflozin · 10 mg tablet, 25 mg tablet
  • Zostat Losartan · 50 mg tablet
Questions

Himont Pharmaceuticals: common questions

How many products does Himont Pharmaceuticals have in Pakistan?

Himont Pharmaceuticals (Pvt.) Ltd has 70 registered medicine presentations in Pakistan, sold under 33 brands and covering 30 generic medicines.

What are the main brands of Himont Pharmaceuticals?

By number of registered strengths and packs, its largest brands are Clotles SS (Enoxaparin), Novosef (Ceftriaxone), Himet (Metformin), Akafin (Ibuprofen) and Atrocard (Atorvastatin). This is not a sales ranking.

Which therapy areas does Himont Pharmaceuticals cover?

The most products are in Anti-infectives (32), Cardiovascular (10), Hematology & thrombosis (10), Endocrine & metabolic (10) and Pain & musculoskeletal (3).

Where can I see Himont Pharmaceuticals medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Himont Pharmaceuticals (Pvt.) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 13, 2026, from https://medinfobase.com/company/himont-pharmaceuticals-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9